PuSH - Publication Server of Helmholtz Zentrum München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Schaule, J.* ; Kroeze, S.G.C.* ; Blanck, O.* ; Stera, S.* ; Kahl, K.H.* ; Roeder, F.* ; Combs, S.E. ; Kaul, D.* ; Claes, A.* ; Schymalla, M.M.* ; Adebahr, S.* ; Eckert, F.* ; Lohaus, F.* ; Abbasi-Senger, N.* ; Henke, G.* ; Szuecs, M.* ; Geier, M.* ; Sundahl, N.* ; Buergy, D.* ; Dummer, R.* ; Guckenberger, M.*

Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy: Melanoma brain metastases prognostic score (Radiation Oncology, (2020), 15, 1, (135), 10.1186/s13014-020-01558-8).

Radiat. Oncol. 15:280 (2020)
Correction DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
An amendment to this paper has been published and can be accessed via the original article.
Altmetric
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Other: Correction, Addition
Language english
Publication Year 2020
HGF-reported in Year 2021
ISSN (print) / ISBN 1748-717X
e-ISSN 1748-717X
Journal Radiation Oncology
Quellenangaben Volume: 15, Issue: 1, Pages: , Article Number: 280 Supplement: ,
Publisher BioMed Central
Publishing Place Campus, 4 Crinan St, London N1 9xw, England
Reviewing status Peer reviewed
Institute(s) Institute of Radiation Medicine (IRM)
POF-Topic(s) 30203 - Molecular Targets and Therapies
Research field(s) Radiation Sciences
PSP Element(s) G-501300-001
DOI 10.1186/s13014-020-01708-y
WOS ID WOS:000599796300001
Scopus ID 85097586518
PubMed ID 33317582
Erfassungsdatum 2021-04-23
[➜Report correction]